Delivery Order SPE2DX15D3012-SPE2DX22F8PS3
- Not listed
- This federal contract award, valued at $39,585.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the provision of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of January 12, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $48,029.51 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The award, which has no set-aside designation, falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,258.73 for the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,657.12 delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award, identified as SPE2DX15D2205|SPE2DX23F81JH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $39,525.36 Firm Fixed Price Delivery Order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc....
- This federal contract award, valued at $22,371.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TREMFYA 100 MG/ML syringes, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award is for $70,469.31 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order (SPE2DB20D1100|SPE2DB24FA3K8) for TREMFYA 100 MG/ML syringes, with a period of performance through February 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TREMFYA 100 MG/ML SYRINGE medical supplies. The award, valued at $35,513.01, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $81,989.05 firm fixed-price delivery order is for the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, identified as SPE2DX15D3007|SPE2DX23F9L8U, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,140.49 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of May 16, 2023. The contract award is not designated as a set-aside and represents one of many delivery orders issued under Cencora, Inc.'s...
- SPE2DX15D3012Indefinite Delivery Contract
- SPE2DX15D3012-SPE2DX22F8PS3Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $89,947.51 delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate Cencora, Inc.'s capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.9k | 9/7/22 |